Serotonin induces a biphasic response in rabbit cavernosal smooth muscle: Relevance to the erectile process

Urologia Internationalis

Volumn 79, Issue 3, 2007, Pages 255-261

  Lau, David H W ^a   Thompson, Cecil S ^a   Mumtaz, Faiz H ^a,b   Morgan, Robert J ^a   Mikhailidis, Dimitri P ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b CHASE FARM HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Cavernosal tone; Corpus cavernosum; Erectile dysfunction; Rabbit; Serotonin

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AZASETRON; DOXAZOSIN; KETANSERIN; ONDANSETRON; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 7 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ERECTILE DYSFUNCTION; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; SEROTONINERGIC SYSTEM; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION; STATISTICAL SIGNIFICANCE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE SYNTHASE; PENILE ERECTION; PENIS; RABBITS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 35348892054     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107959     Document Type: Article

References (37)

1. NIH Consensus Development Panel on Impotence: NIH Consensus Development Panel on Impotence. Am Med Assoc 1993;270:90.
2. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M: The Multinational Men's Attitudes to Life Events and Sexuality (MALES) Study. I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004;20:607-617.
3. Carson CC: Erectile dysfunction: evaluation and new treatment options. Psychosom Med 2004;66:664-671.
4. Martin GR, Humphrey PP: Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology 1994;33:261-273.
5. Hull EM, Muschamp JW, Sato S: Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 2004;83:291-307.
6. Bancila M, Giuliano F, Rampin O, Mailly P, Brisorgueil MJ, Calas A, Verge D: Evidence for a direct projection from the paraventricular nucleus of the hypothalamus to putative serotoninergic neurons of the nucleus paragigantocellularis involved in the control of erection in rats. Eur J Neurosci 2002;16:1240-1248.
7. Ahlenius S, Larsson K, Arvidsson LE: Effects of stereoselective 5-HT1A agonists on male rat sexual behavior. Pharmacol Biochem Behav 1989;33:691-695.
8. 1A receptor. Brain Res 1999;821:414-425.
9. Steers WD: Neural control of penile erection. Semin Urol 1990;8:66-79.
10. 2C receptors on spinal neurons controlling penile erection in the rat. Neuroscience 1999;92:1523-1537.
11. Brotto LA, Gorzalka BB: Melatonin enhances sexual behavior in the male rat. Physiol Behav 2000;68:483-486.
12. Angulo J, Peiro C, Sanchez-Ferrer CF, Gabancho S, Cuevas P, Gupta S, Saenz de Tejada I: Differential effects of serotonin reuptake inhibitors on erectile responses, NO production, and neuronal NO synthase expression in rat corpus cavernosum tissue. Br J Pharmacol 2001;34:1190-1194.
13. Rothman RB, Baumann MH: Serotonin-releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav 2002;71:825-836.
14. Myrick H, Markowitz JS, Henderson S: Priapism following trazodone overdose with cocaine use. Ann Clin Psych 1998;10:81-83.
15. Finberg JP, Vardi Y: Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat. Br J Pharmacol 1990;101:698-702.
16. Esen AA, Gidener S, Guler C, Guven H, Kirkali Z: Contractility changes of the deep dorsal penile vein due to serotonin. J Urol 1997;158:234-237.
17. Furukawa K, Nagao K, Ishii N, Uchiyama T: Responses to serotonin (5-HT) in isolated corpus cavernosum penis of rabbit. Int J Impot Res 2003;15:267-271.
18. 1 agonists on erection in rats in vivo and rabbit corpus cavernosum in vitro. Int J Impot Res 2002;14:205-212.
19. Lau DHW, Thompson CS, Bellringer JF, Thomas PJ, Mumtaz FH, Morgan RJ, Mikhailidis DP: Doxazosin and serotonin (5-HT) receptor (1A, 2A and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction. J Androl 2006;27:679-685.
20. Uckert S, Fuhlenriede MH, Becker AJ, Stief CG, Scheller F, Knapp WH, Forssmann V, Jonas U: Is serotonin significant for the control of penile flaccidity and detumescence in the human male? Urol Res 2003;31:55-60.
21. Hayes ES, Adaikan PG, Ratnam SS, Ng SC: 5-HT 4 receptors in isolated human corpus cavernosum? Int J Impot Res 1999;11:219-225.
22. De Rose AF, Giglio M, Traverso P, Lantieri P, Carmignani G: Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy. Int J Impot Res 2002;14:50-53.
23. Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE: Combination therapy using oral α-blockers and intracavernosal injection in men with erectile dysfunction. Urology 1998;52:43.
24. 1 alone. Br J Urol 1996;77:736-739.
25. Petersen J, Schmidt PF, Meyhoff HH, Frimodt-Moller C: The effects of a new serotonin receptor antagonist (ketanserin) on lower urinary tract function in patients with prostatism. J Urol 1985;133:1094-1098.
26. 3 receptors on vagal afferents mediating the Bezold-Jarisch reflex. Brain Res 2000;873:302-305.
27. 2 receptor subtypes in the Suncus murinus intestine. Eur J Pharmacol 1999;381:161-169.
28. 3 receptor agonist. Bioorg Med Chem 2003;11:2709-2714.
29. Sicuteri F: Is acute tolerance to 5-hydroxytryptamine opioid dependent? Its absence in migraine sufferers. Cephalalgia 1983;3:187-190.
30. Khan MA, Thompson CS, Dashwood MR, Mumtaz FH, Mikhailidis DP, Morgan RJ: Doxazosin modifies serotonin-mediated rabbit urinary bladder contraction. Urol Res 2000;28:116-121.
31. Webber SE, Salonen RO, Widdicombe JG: Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep. Br J Pharmacol 1990;99:21-26.
32. Kanada A, Hosokawa M, Suthamnatpong N, Maehara T, Takeuchi T, Hata F: Neuronal pathway involved in nitric oxide-mediated descending relaxation in rat ileum. Eur J Pharmacol 1993;250:59-66.
33. 2+ ionophore raise cyclic GMP levels in a neuronal cell line via formation of nitric oxide. Br J Pharmacol 1990;101:722-726.
34. Inoue A, Hashimoto T, Hide I, Nishio H, Nakata Y: 5-Hydroxytryptamine- facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP. J Neurochem 1997;68:128-133.
35. 1- adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets. J Human Hypertens 2001;15:203-207.
36. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 1993;361:315-325.
37. Cellek S: Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction. Drugs Today (Barc) 2000;36:135-146.